Cresco Labs experienced significant corporate restructuring, operational streamlining, and asset portfolio optimization following shifting dynamics in the North American cannabis market. The company faced headwinds related to federal rescheduling delays, compressed wholesale pricing for cannabis biomass, and competitive pressures across key state markets, prompting management to focus heavily on cost efficiencies, operational profitability, and debt reduction.